| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |